These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


93 related items for PubMed ID: 6543122

  • 1. Antagonism by supidimide of haloperidol-induced augmentation of [3H]-spiperone binding in rat striatum.
    Hennies HH, Hess V, Flohé L.
    Arzneimittelforschung; 1984; 34(11):1481-4. PubMed ID: 6543122
    [Abstract] [Full Text] [Related]

  • 2. Influence of supidimide on brain neurotransmitter systems of rats and mice.
    Hennies HH, Günzler WA, Flohé L.
    Arzneimittelforschung; 1984; 34(11):1471-80. PubMed ID: 6084511
    [Abstract] [Full Text] [Related]

  • 3. Lasting changes in high affinity 3H-spiperone binding to the rat striatum and mesolimbic area after chronic methamphetamine administration: evaluation of dopaminergic and serotonergic receptor components.
    Akiyama K, Sato M, Kashihara K, Otsuki S.
    Biol Psychiatry; 1982 Dec; 17(12):1389-402. PubMed ID: 7159638
    [Abstract] [Full Text] [Related]

  • 4. Increased 3H-spiperone binding sites in mesolimbic area related to methamphetamine-induced behavioral hypersensitivity.
    Akiyama K, Sato M, Otsuki S.
    Biol Psychiatry; 1982 Feb; 17(2):223-31. PubMed ID: 7200378
    [Abstract] [Full Text] [Related]

  • 5. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR, Dubocovich ML.
    J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
    [Abstract] [Full Text] [Related]

  • 6. Are striatal [3H]spiperone radioreceptor assays indicative of multiple dopamine receptor interactions?
    Clements-Jewery S, Robson PA.
    Neuropharmacology; 1981 Dec; 20(12B):1295-8. PubMed ID: 7322304
    [No Abstract] [Full Text] [Related]

  • 7. Agonist interactions with [3H]-spiperone binding sites on rat corpus striatum membranes [proceedings].
    Howlett DR, Morris H, Nahorski SR.
    Br J Pharmacol; 1979 May; 66(1):136P. PubMed ID: 454928
    [No Abstract] [Full Text] [Related]

  • 8. Effects of chronic haloperidol, thioridazine and zotepine treatment on apomorphine elicited stereotypic behavior and 3H-spiroperidol binding sites in the striatum of the rat.
    Lai HC, Carino MA, Horita A.
    Proc West Pharmacol Soc; 1981 May; 24():5-6. PubMed ID: 6114496
    [No Abstract] [Full Text] [Related]

  • 9. Analysis of dopamine interactions with [3H]-spiperone binding sites on rat corpus striatum membranes [proceedings].
    Howlett DR, Nahorski SR.
    Br J Pharmacol; 1979 Jul; 66(3):468P-469P. PubMed ID: 526752
    [No Abstract] [Full Text] [Related]

  • 10. Estimation of the apparent affinity of the striatal dopamine receptors for the radioligand[3H]spiperone [( 3H]spiroperidol).
    Hruska RE.
    J Neurosci Res; 1984 Jul; 12(4):571-81. PubMed ID: 6512888
    [Abstract] [Full Text] [Related]

  • 11. Quantification of in vivo spiperone binding in the rat striatum after lesions produced by kainate or decortication.
    Van der Werf JF, Van het Schip F, Sebens JB, Korf J.
    Eur J Pharmacol; 1984 Jul 20; 102(3-4):387-99. PubMed ID: 6436037
    [Abstract] [Full Text] [Related]

  • 12. Chronic haloperidol affects striatal D2-dopamine receptor reappearance after irreversible receptor blockade.
    Pich EM, Benfenati F, Farabegoli C, Fuxe K, Meller E, Aronsson M, Goldstein M, Agnati LF.
    Brain Res; 1987 Dec 01; 435(1-2):147-52. PubMed ID: 2962698
    [Abstract] [Full Text] [Related]

  • 13. Increase in in vivo (3H) spiperone binding in the rat hippocampal formation and striatum after repeated treatment with haloperidol.
    Bischoff S.
    Experientia; 1981 Dec 01; 37(9):1008-9. PubMed ID: 7297644
    [Abstract] [Full Text] [Related]

  • 14. Factors contributing to the up regulation of dopaminergic receptors by chronic haloperidol.
    Schweitzer JW, Schwartz R, Friedhoff AJ.
    Res Commun Chem Pathol Pharmacol; 1982 Oct 01; 38(1):21-30. PubMed ID: 7146618
    [Abstract] [Full Text] [Related]

  • 15. Anomalous properties of [3H]spiperone binding sites in various areas of the rat limbic system.
    Howlett DR, Morris H, Nahorski SR.
    Mol Pharmacol; 1979 May 01; 15(3):506-14. PubMed ID: 492143
    [No Abstract] [Full Text] [Related]

  • 16. Chronic domperidone fails to increase striatal spiperone binding sites despite hyperprolactinemia: comparison with chronic haloperidol.
    Morgan DG, Sinha YN, Finch CE.
    Neuroendocrinology; 1984 May 01; 38(5):407-10. PubMed ID: 6728123
    [Abstract] [Full Text] [Related]

  • 17. Dopamine-mediated behaviour and 3H-spiperone binding to striatal membranes in rats after nine months haloperidol administration.
    Owen F, Cross AJ, Waddington JL, Poulter M, Gamble SJ, Crow TJ.
    Life Sci; 1980 Jan 07; 26(1):55-9. PubMed ID: 7189005
    [No Abstract] [Full Text] [Related]

  • 18. Postsynaptic location of acrylamide-induced modulation of striatal 3H-spiroperidol binding.
    Hong JS, Tilson HA, Agrawal AK, Karoum F, Bondy SC.
    Neurotoxicology; 1982 Jul 07; 3(1):108-12. PubMed ID: 6890181
    [Abstract] [Full Text] [Related]

  • 19. A comparative study of [3H]haloperidol and [3H]spiroperidol binding to receptors on rat cerebral membranes.
    Howlett DR, Nahorski SR.
    FEBS Lett; 1978 Mar 01; 87(1):152-6. PubMed ID: 631328
    [No Abstract] [Full Text] [Related]

  • 20. [Effect of in vitro serotonin on dopaminergic binding sites in rat striatal membranes].
    Oelssner W, Raubach KH, Oelssner W.
    Biomed Biochim Acta; 1983 Mar 01; 42(7-8):931-6. PubMed ID: 6651809
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.